BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taracanova A, Tsilioni I, Conti P, Norwitz ER, Leeman SE, Theoharides TC. Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin. Proc Natl Acad Sci U S A 2018;115:E9381-90. [PMID: 30232261 DOI: 10.1073/pnas.1810133115] [Cited by in Crossref: 36] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Mahdiani S, Omidkhoda N, Heidari S, Hayes AW, Karimi G. Protective effect of luteolin against chemical and natural toxicants by targeting NF-κB pathway. Biofactors 2022. [PMID: 35861671 DOI: 10.1002/biof.1876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zheng Y, Wang N, Chen Z, Shi L, Xu X. Blocking SP/NK1R signaling improves spinal cord hemisection by inhibiting the release of pro-inflammatory cytokines in rabbits. J Spinal Cord Med 2022;:1-11. [PMID: 35776091 DOI: 10.1080/10790268.2021.2024029] [Reference Citation Analysis]
3 Kassianidis G, Siampanos A, Poulakou G, Adamis G, Rapti A, Milionis H, Dalekos GN, Petrakis V, Sympardi S, Metallidis S, Alexiou Z, Gkavogianni T, Giamarellos-Bourboulis EJ, Theoharides TC. Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19. Int J Mol Sci 2022;23:4894. [PMID: 35563282 DOI: 10.3390/ijms23094894] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Xie YZ, Peng CW, Su ZQ, Huang HT, Liu XH, Zhan SF, Huang XF. A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis. Front Immunol 2021;12:769011. [PMID: 35069542 DOI: 10.3389/fimmu.2021.769011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Theoharides TC. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol Neurobiol 2022. [PMID: 35028901 DOI: 10.1007/s12035-021-02696-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
6 Lam HY, Tergaonkar V, Kumar AP, Ahn KS. Mast cells: Therapeutic targets for COVID-19 and beyond. IUBMB Life 2021;73:1278-92. [PMID: 34467628 DOI: 10.1002/iub.2552] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Theoharides TC. Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder. J Pers Med 2021;11:860. [PMID: 34575637 DOI: 10.3390/jpm11090860] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Conti P, Pregliasco FE, Bellomo RG, Gallenga CE, Caraffa A, Kritas SK, Lauritano D, Ronconi G. Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra. Int J Mol Sci 2021;22:8076. [PMID: 34360845 DOI: 10.3390/ijms22158076] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
9 Hafezi B, Chan L, Knapp JP, Karimi N, Alizadeh K, Mehrani Y, Bridle BW, Karimi K. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells. Cells 2021;10:1761. [PMID: 34359931 DOI: 10.3390/cells10071761] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
10 Wong LS, Yen YT, Lee CH. The Implications of Pruritogens in the Pathogenesis of Atopic Dermatitis. Int J Mol Sci 2021;22:7227. [PMID: 34281281 DOI: 10.3390/ijms22137227] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Mai L, Liu Q, Huang F, He H, Fan W. Involvement of Mast Cells in the Pathophysiology of Pain. Front Cell Neurosci 2021;15:665066. [PMID: 34177465 DOI: 10.3389/fncel.2021.665066] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
12 Alesci A, Aragona M, Cicero N, Lauriano ER. Can nutraceuticals assist treatment and improve covid-19 symptoms? Nat Prod Res 2021;:1-20. [PMID: 33949266 DOI: 10.1080/14786419.2021.1914032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors 2021;47:232-41. [PMID: 33847020 DOI: 10.1002/biof.1726] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 29.0] [Reference Citation Analysis]
14 Saikumar Jayalatha AK, Hesse L, Ketelaar ME, Koppelman GH, Nawijn MC. The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention. Pharmacol Ther 2021;225:107847. [PMID: 33819560 DOI: 10.1016/j.pharmthera.2021.107847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
15 Franke K, Wang Z, Zuberbier T, Babina M. Cytokines Stimulated by IL-33 in Human Skin Mast Cells: Involvement of NF-κB and p38 at Distinct Levels and Potent Co-Operation with FcεRI and MRGPRX2. Int J Mol Sci 2021;22:3580. [PMID: 33808264 DOI: 10.3390/ijms22073580] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
16 Conti P, Caraffa A, Gallenga CE, Ross R, Kritas SK, Frydas I, Younes A, Di Emidio P, Ronconi G, Pandolfi F. Powerful anti-inflammatory action of luteolin: Potential increase with IL-38. Biofactors 2021;47:165-9. [PMID: 33755250 DOI: 10.1002/biof.1718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Delgado A, Cholevas C, Theoharides TC. Neuroinflammation in Alzheimer's disease and beneficial action of luteolin. Biofactors 2021;47:207-17. [PMID: 33615581 DOI: 10.1002/biof.1714] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
18 Ammendola M, Currò G, Laface C, Zuccalà V, Memeo R, Luposella F, Laforgia M, Zizzo N, Zito A, Loisi D, Patruno R, Milella L, Ugenti I, Porcelli M, Navarra G, Gadaleta CD, Ranieri G. Mast Cells Positive for c-Kit Receptor and Tryptase Correlate with Angiogenesis in Cancerous and Adjacent Normal Pancreatic Tissue. Cells 2021;10:444. [PMID: 33669751 DOI: 10.3390/cells10020444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Demopoulos C, Antonopoulou S, Theoharides TC. COVID-19, microthromboses, inflammation, and platelet activating factor. Biofactors 2020;46:927-33. [PMID: 33296106 DOI: 10.1002/biof.1696] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
20 Theoharides TC. Luteolin supplements: All that glitters is not gold. Biofactors 2021;47:242-4. [PMID: 33159817 DOI: 10.1002/biof.1689] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Falduto GH, Pfeiffer A, Luker A, Metcalfe DD, Olivera A. Emerging mechanisms contributing to mast cell-mediated pathophysiology with therapeutic implications. Pharmacol Ther 2021;220:107718. [PMID: 33130192 DOI: 10.1016/j.pharmthera.2020.107718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
22 Yin C, Liu B, Li Y, Li X, Wang J, Chen R, Tai Y, Shou Q, Wang P, Shao X, Liang Y, Zhou H, Mi W, Fang J, Liu B. IL-33/ST2 induces neutrophil-dependent reactive oxygen species production and mediates gout pain. Theranostics 2020;10:12189-203. [PMID: 33204337 DOI: 10.7150/thno.48028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
23 Brzoza Z, Rymarczyk B, Grzeszczak W, Trautsolt W, Pluta-Kubicz M, Moczulski D. Interleukin 1 Gene Polymorphisms Presumably Participate in the Pathogenesis of Chronic Spontaneous Autoreactive Urticaria. J Interferon Cytokine Res 2020;40:497-500. [PMID: 33064598 DOI: 10.1089/jir.2020.0103] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Papathanasiou E, Conti P, Carinci F, Lauritano D, Theoharides TC. IL-1 Superfamily Members and Periodontal Diseases. J Dent Res 2020;99:1425-34. [PMID: 32758110 DOI: 10.1177/0022034520945209] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
25 Theoharides TC. The impact of psychological stress on mast cells. Ann Allergy Asthma Immunol 2020;125:388-92. [PMID: 32687989 DOI: 10.1016/j.anai.2020.07.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
26 Eissmann MF, Buchert M, Ernst M. IL33 and Mast Cells-The Key Regulators of Immune Responses in Gastrointestinal Cancers? Front Immunol 2020;11:1389. [PMID: 32719677 DOI: 10.3389/fimmu.2020.01389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
27 Song Y, Lu M, Yuan H, Chen T, Han X. Mast cell-mediated neuroinflammation may have a role in attention deficit hyperactivity disorder (Review). Exp Ther Med 2020;20:714-26. [PMID: 32742317 DOI: 10.3892/etm.2020.8789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
28 Theoharides TC. Effect of Stress on Neuroimmune Processes. Clin Ther 2020;42:1007-14. [PMID: 32451121 DOI: 10.1016/j.clinthera.2020.05.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
29 Beute J, Ganesh K, Nastiti H, Hoogenboom R, Bos V, Folkerts J, Schreurs MWJ, Hockman S, Hendriks RW, KleinJan A. PDE3 Inhibition Reduces Epithelial Mast Cell Numbers in Allergic Airway Inflammation and Attenuates Degranulation of Basophils and Mast Cells. Front Pharmacol 2020;11:470. [PMID: 32425769 DOI: 10.3389/fphar.2020.00470] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
30 Theoharides TC. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin. Biofactors 2020;46:306-8. [PMID: 32339387 DOI: 10.1002/biof.1633] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 34.5] [Reference Citation Analysis]
31 Pondeljak N, Lugović-Mihić L. Stress-induced Interaction of Skin Immune Cells, Hormones, and Neurotransmitters. Clin Ther 2020;42:757-70. [PMID: 32276734 DOI: 10.1016/j.clinthera.2020.03.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
32 Lauritano D, Ronconi G, Caraffa A, Enrica Gallenga C, Kritas SK, Di Emidio P, Martinotti S, Tetè G, Ross R, Conti P. New aspect of allergic contact dermatitis, an inflammatory skin disorder mediated by mast cells: Can IL-38 help? Med Hypotheses 2020;139:109687. [PMID: 32259663 DOI: 10.1016/j.mehy.2020.109687] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
33 Conti P, Lauritano D, Caraffa A, Gallenga CE, Kritas SK, Ronconi G, Martinotti S. Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37. Eur J Pharmacol 2020;875:173035. [PMID: 32097657 DOI: 10.1016/j.ejphar.2020.173035] [Cited by in Crossref: 18] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
34 Theoharides TC, Tsilioni I. Amyotrophic Lateral Sclerosis, Neuroinflammation, and Cromolyn. Clin Ther 2020;42:546-9. [PMID: 32044139 DOI: 10.1016/j.clinthera.2020.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Varricchi G, Marone G. Mast Cells: Fascinating but Still Elusive after 140 Years from Their Discovery. Int J Mol Sci 2020;21:E464. [PMID: 31940755 DOI: 10.3390/ijms21020464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
36 Bawazeer MA, Theoharides TC. IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-κB, inhibited by methoxyluteolin. Eur J Pharmacol 2019;865:172760. [PMID: 31669588 DOI: 10.1016/j.ejphar.2019.172760] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
37 Siiskonen H, Harvima I. Mast Cells and Sensory Nerves Contribute to Neurogenic Inflammation and Pruritus in Chronic Skin Inflammation. Front Cell Neurosci 2019;13:422. [PMID: 31619965 DOI: 10.3389/fncel.2019.00422] [Cited by in Crossref: 27] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
38 Conti P, Lauritano D, Caraffa A, Gallenga CE, Kritas SK, Ronconi G, Pandolfi F. New insight into systemic mastocytosis mediated by cytokines IL-1β and IL-33: Potential inhibitory effect of IL-37. European Journal of Pharmacology 2019;858:172473. [DOI: 10.1016/j.ejphar.2019.172473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Theoharides TC, Tsilioni I, Bawazeer M. Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome. Front Cell Neurosci 2019;13:353. [PMID: 31427928 DOI: 10.3389/fncel.2019.00353] [Cited by in Crossref: 25] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
40 Theoharides TC, Tsilioni I, Conti P. Mast Cells May Regulate The Anti-Inflammatory Activity of IL-37. Int J Mol Sci 2019;20:E3701. [PMID: 31362339 DOI: 10.3390/ijms20153701] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
41 Theoharides TC, Kavalioti M, Tsilioni I. Mast Cells, Stress, Fear and Autism Spectrum Disorder. Int J Mol Sci 2019;20:E3611. [PMID: 31344805 DOI: 10.3390/ijms20153611] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
42 Varricchi G, Pecoraro A, Loffredo S, Poto R, Rivellese F, Genovese A, Marone G, Spadaro G. Heterogeneity of Human Mast Cells With Respect to MRGPRX2 Receptor Expression and Function. Front Cell Neurosci 2019;13:299. [PMID: 31333418 DOI: 10.3389/fncel.2019.00299] [Cited by in Crossref: 33] [Cited by in F6Publishing: 43] [Article Influence: 11.0] [Reference Citation Analysis]
43 Theoharides TC, Tsilioni I, Ren H. Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders? Expert Rev Clin Immunol 2019;15:639-56. [PMID: 30884251 DOI: 10.1080/1744666X.2019.1596800] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
44 Mittal A, Sagi V, Gupta M, Gupta K. Mast Cell Neural Interactions in Health and Disease. Front Cell Neurosci 2019;13:110. [PMID: 30949032 DOI: 10.3389/fncel.2019.00110] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
45 Tran H, Mittal A, Sagi V, Luk K, Nguyen A, Gupta M, Nguyen J, Lamarre Y, Lei J, Guedes A, Gupta K. Mast Cells Induce Blood Brain Barrier Damage in SCD by Causing Endoplasmic Reticulum Stress in the Endothelium. Front Cell Neurosci 2019;13:56. [PMID: 30837844 DOI: 10.3389/fncel.2019.00056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
46 Theoharides TC, Leeman SE. Effect of IL-33 on de novo synthesized mediators from human mast cells. Journal of Allergy and Clinical Immunology 2019;143:451. [DOI: 10.1016/j.jaci.2018.09.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]